Skip to main content
Premium Trial:

Request an Annual Quote

Life Technologies Establishes $750M Credit Facility

NEW YORK (GenomeWeb News) – Life Technologies has entered into an agreement to establish a $750 million revolving credit facility, it disclosed in a document filed with the US Securities and Exchange Commission after the close of the market on Tuesday.

Bank of America is the administrative agent, swing line lender, and L/C issuer under the arrangement. Life Tech along with Applied Biosystems BV, Life Technologies Europe BV, and Life Technologies Finance Limited have the right to borrow under the facility.

The facility replaces an earlier $500 million amended and restated credit agreement entered into on May 28, 2010.

Proceeds will go toward ongoing working capital and general corporate purposes of Life Tech and its subsidiaries, it said. The facility terminates on Feb. 14, 2017, at which time all amounts outstanding, plus accrued interest, will be due.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.